FDA: COVID Shots Approved For Kids Under 5
Shots could be in toddlers’ arms soon, pending approval from the CDC.
A government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens.
This new vaccine combines Moderna's original shot with protection against the omicron variant. It gave an eight-fold increase in antibodies, a preliminary study found.
“At the end of the day we all want to move fast, but we’ve got to get it right," said White House COVID-19 coordinator Aashish Jha.
Moderna is asking U.S. regulators to open its COVID-19 vaccine to children younger than 6.
This fourth coronavirus vaccine dose would be optional, and federal health officials aren't currently recommending it for everyone in this age group.
The nation’s 18 million children under 5 are the only age group not yet eligible for vaccination.
The request is broader than rival pharmaceutical company Pfizer's request earlier this week for the regulator to approve a booster shot for all seniors.
The decision was bolstered by real-world evidence from the more than 200 million doses administered in the U.S. since December 2020.